Newswire

Antitrust

Lawsuit Filings

Allergan Facing Latest Restasis Antitrust Suit in Texas

Allergan Facing Latest Restasis Antitrust Suit in Texas

January 17, 2018 Allergan, Inc. has faced a series of lawsuits alleging it unlawfully delayed the entrance to the market of generic alternatives to its cyclosporine ophthalmic emulsion drug, Restasis, causing consumers to be overcharged for the medicine.